DCM-PROGRESS: predicting end-stage heart failure in non-ischemic dilated cardiomyopathy patients

AIMS: Patients with non-ischemic dilated cardiomyopathy (DCM) are at considerable risk for end-stage heart failure (HF), requiring close monitoring to identify early signs of disease. We aimed to develop a model to predict the 5-years risk of end-stage HF, allowing for tailored patient monitoring an...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, A F, Leinveber, P, Panovsky, R, Soukup, L, Machac, P, van de Leur, R R, Sammani, A, Lekadir, K, ter Riele, A, Asselbergs, F W, Boonstra, M J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516079/
https://www.ncbi.nlm.nih.gov/pubmed/37745419
http://dx.doi.org/10.1101/2023.09.10.23295251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516079/
https://www.ncbi.nlm.nih.gov/pubmed/37745419
http://dx.doi.org/10.1101/2023.09.10.23295251

Ejemplares similares